Amplify Treatments, Testing And Advancements ETF IMCR Holdings History
Amplify Treatments, Testing and Advancements ETF's Immunocore Holdings PLC Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 9,166.00 shares of Immunocore Holdings PLC(IMCR), totaling $310,640.00. This investment constitutes 3.4% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0.02% of the outstanding Immunocore Holdings PLC(IMCR) stock.
The initial trade took place in 2024Q1. And since then Amplify Treatments, Testing and Advancements ETF has made 1 purchases of IMCR, at an average price of $63.52, for a total of 9,166.00 shares. Based on historical transaction data and IMCR's current price of $36.93, Amplify Treatments, Testing and Advancements ETF's estimated gain on his IMCR holdings is $-243,736.92, reflecting a -41.86% gain to date.
Amplify Treatments, Testing and Advancements ETF IMCR ($36.93) Holding Chart
Amplify Treatments, Testing and Advancements ETF IMCR ($36.93) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
